Safety and effectiveness of risedronate in Paget ’s disease of bone: postmarketing surveillance study in Japan

ConclusionTo conclude, risedronate 17.5  mg/day is safe and effective for treating patients with PDB in daily practice.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research